ABIVAX Société Anonyme
ABVX
$82.28
-$3.59-4.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.19M | 1.02M | 2.14M | 2.20M | 6.04M |
| Total Revenue | 1.19M | 1.02M | 2.14M | 2.20M | 6.04M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.19M | 1.02M | 2.14M | 2.20M | 6.04M |
| SG&A Expenses | 10.15M | 9.36M | 8.92M | 9.20M | 12.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -52.20K | -25.30K | -867.70K | -894.90K | -19.40K |
| Total Operating Expenses | 53.96M | 50.69M | 51.70M | 53.32M | 44.06M |
| Operating Income | -52.77M | -49.67M | -49.56M | -51.11M | -38.02M |
| Income Before Tax | -54.95M | -55.11M | -50.42M | -52.00M | -41.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.95M | -55.11M | -50.42M | -52.00M | -41.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.95M | -55.11M | -50.42M | -52.00M | -41.73M |
| EBIT | -52.77M | -49.67M | -49.56M | -51.11M | -38.02M |
| EBITDA | -52.74M | -49.59M | -49.07M | -50.60M | -37.91M |
| EPS Basic | -0.87 | -0.87 | -0.80 | -0.82 | -0.66 |
| Normalized Basic EPS | -0.54 | -0.53 | -0.50 | -0.51 | -0.41 |
| EPS Diluted | -0.87 | -0.87 | -0.80 | -0.82 | -0.66 |
| Normalized Diluted EPS | -0.54 | -0.53 | -0.50 | -0.51 | -0.41 |
| Average Basic Shares Outstanding | 63.44M | 63.38M | 63.17M | 63.17M | 62.92M |
| Average Diluted Shares Outstanding | 63.44M | 63.38M | 63.17M | 63.17M | 62.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |